Clinical trials: Arsenic Exposure
Arsenic Metabolites Measured in Urine
A Preliminary Study of Choline and Betaine Supplementation Among Adults Exposed to Arsenic in Bangladesh
Roughly 140 million people worldwide are chronically exposed to As-contaminated drinking water at concentrations exceeding the World Health Organization (WHO) standard of 10 µg/L.
- Trial name
- CABS (NCT01749982)
- Testing
- Choline bitartrate, Betaine, Choline bitartrate + Betaine
- Where
- Bangladesh
- Volunteers
- 60 people
- Sponsor
- Columbia University
Chronic Pruritus
Treatment of Chronic Itch in Patients Under Arsenic Exposure With Naloxone
The purpose of this study is to assess the efficacy and safety of sublingual naloxone in the treatment of chronic itch in patients under arsenic exposure.
- Trial name
- NCT03751111
- Testing
- Naloxone
- Where
- China
- Volunteers
- 126 people
- Sponsor
- Xiangya Hospital of Central South University